147 related articles for article (PubMed ID: 23188760)
1. HCV's days are numbered: next-generation direct-acting antivirals and host-targeting agents.
Calle Serrano B; Manns MP
Antivir Ther; 2012; 17(6 Pt B):1133-46. PubMed ID: 23188760
[TBL] [Abstract][Full Text] [Related]
2. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
Halfon P; Sarrazin C
Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
[TBL] [Abstract][Full Text] [Related]
3. The science of direct-acting antiviral and host-targeted agent therapy.
Pawlotsky JM
Antivir Ther; 2012; 17(6 Pt B):1109-17. PubMed ID: 23188746
[TBL] [Abstract][Full Text] [Related]
4. Asunaprevir-containing regimens for the treatment of hepatitis C virus infection.
Yang SS; Kao JH
Expert Rev Gastroenterol Hepatol; 2015 Jan; 9(1):9-20. PubMed ID: 25174254
[TBL] [Abstract][Full Text] [Related]
5. [Antiviral treatment of chronic hepatitis C].
Berger A
Med Monatsschr Pharm; 2012 Feb; 35(2):55-60. PubMed ID: 22400430
[TBL] [Abstract][Full Text] [Related]
6. Targets for antiviral therapy of hepatitis C.
Rupp D; Bartenschlager R
Semin Liver Dis; 2014 Feb; 34(1):9-21. PubMed ID: 24782254
[TBL] [Abstract][Full Text] [Related]
7. Antiviral resistance and direct-acting antiviral agents for HCV.
Aloia AL; Locarnini S; Beard MR
Antivir Ther; 2012; 17(6 Pt B):1147-62. PubMed ID: 23188771
[TBL] [Abstract][Full Text] [Related]
8. Future perspectives: towards interferon-free regimens for HCV.
Gane E
Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus resistance to protease inhibitors.
Halfon P; Locarnini S
J Hepatol; 2011 Jul; 55(1):192-206. PubMed ID: 21284949
[TBL] [Abstract][Full Text] [Related]
10. Are statins a viable option for the treatment of infections with the hepatitis C virus?
Verpaalen B; Neyts J; Delang L
Antiviral Res; 2014 May; 105():92-9. PubMed ID: 24613180
[TBL] [Abstract][Full Text] [Related]
11. New antiviral therapies in the management of HCV infection.
Farnik H; Zeuzem S
Antivir Ther; 2012; 17(5):771-83. PubMed ID: 22626842
[TBL] [Abstract][Full Text] [Related]
12. Directly acting antivirals against hepatitis C virus.
Soriano V; Vispo E; Poveda E; Labarga P; Martin-Carbonero L; Fernandez-Montero JV; Barreiro P
J Antimicrob Chemother; 2011 Aug; 66(8):1673-86. PubMed ID: 21652618
[TBL] [Abstract][Full Text] [Related]
13. [Future of antiviral therapy for chronic hepatitis C. Direct antiviral acting medications].
Lange CM; Sarrazin C; Zeuzem S
Pharm Unserer Zeit; 2011 Jan; 40(1):60-7. PubMed ID: 21194084
[No Abstract] [Full Text] [Related]
14. The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.
Gentile I; Carleo MA; Borgia F; Castaldo G; Borgia G
Expert Opin Investig Drugs; 2010 Jan; 19(1):151-9. PubMed ID: 20001560
[TBL] [Abstract][Full Text] [Related]
15. The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.
Marks KM; Jacobson IM
Antivir Ther; 2012; 17(6 Pt B):1119-31. PubMed ID: 23188750
[TBL] [Abstract][Full Text] [Related]
16. Second generation direct antivirals and the way to interferon-free regimens in chronic HCV.
Lewis H; Cunningham M; Foster G
Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):471-85. PubMed ID: 23199506
[TBL] [Abstract][Full Text] [Related]
17. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
Suzuki T
Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus--biology, host evasion strategies, and promising new therapies on the horizon.
Qureshi SA
Med Res Rev; 2007 May; 27(3):353-73. PubMed ID: 16958135
[TBL] [Abstract][Full Text] [Related]
19. Symbiotic chemo- and immuno-therapy for hepatitis B and C viruses.
Agrawal B; Kumar R
World J Gastroenterol; 2016 Jul; 22(25):5623-6. PubMed ID: 27433078
[TBL] [Abstract][Full Text] [Related]
20. Anti-hepatitis C virus drugs in development.
Schaefer EA; Chung RT
Gastroenterology; 2012 May; 142(6):1340-1350.e1. PubMed ID: 22537441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
